Weekly Recap: Sale of minority stake in contraceptives unit and €2B hybrid bond

Bayer AG (XETR:BAYN) raised roughly €3bn by selling a minority stake in its long—acting contraceptives unit to Apollo, issued €2bn of hybrid bonds (non—call 6y 5.75%, 9y 6.25%), and agreed to sell Stivarga rights to Grünenthal for up to €375m, closing by 2026/27.Previous Week RecapThis is an AI-gen…